LEXAGENE HOLDINGS INC (LXG.CA) Stock Price, Forecast & Analysis

Canada • TSX Venture Exchange • TSX-V:LXG • CA52886L1031

0.105 CAD
-0.03 (-19.23%)
Last: Feb 21, 2023, 07:00 PM

LXG.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap14.77M
Revenue(TTM)194.46K
Net Income(TTM)-16.51M
Shares140.64M
Float120.87M
52 Week High0.3
52 Week Low0.07
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-0.18
PEN/A
Fwd PEN/A
Earnings (Next)N/A
IPO2007-08-28
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
LXG.CA short term performance overview.The bars show the price performance of LXG.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -20 -40 -60

LXG.CA long term performance overview.The bars show the price performance of LXG.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of LXG.CA is 0.105 CAD. In the past month the price decreased by -62.5%. In the past year, price decreased by -63.16%.

LEXAGENE HOLDINGS INC / LXG Daily stock chart

LXG.CA Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

LXG.CA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to LXG.CA. LXG.CA may be in some trouble as it scores bad on both profitability and health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

LXG.CA Financial Highlights

Over the last trailing twelve months LXG.CA reported a non-GAAP Earnings per Share(EPS) of -0.18. The EPS decreased by -45.78% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity 0.44
Chartmill High Growth Momentum
EPS Q2Q%46.52%
Sales Q2Q%-11.18%
EPS 1Y (TTM)-45.78%
Revenue 1Y (TTM)32.22%

LXG.CA Forecast & Estimates

9 analysts have analysed LXG.CA and the average price target is 0.51 CAD. This implies a price increase of 385.71% is expected in the next year compared to the current price of 0.105.


Analysts
Analysts84.44
Price Target0.51 (385.71%)
EPS Next YN/A
Revenue Next YearN/A

LXG.CA Ownership

Ownership
Inst Owners0%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

LXG.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
PRN.CA PROFOUND MEDICAL CORP N/A 289.52M
TLT.CA THERALASE TECHNOLOGIES INC N/A 66.90M
MIR.CA MEDMIRA INC N/A 49.29M
CNVI.CA CONAVI MEDICAL CORP N/A 33.77M
PINK.CA PERIMETER MEDICAL IMAGING AI N/A 31.74M
ASG.CA AURORA SPINE CORP N/A 22.78M
VPT.CA VENTRIPOINT DIAGNOSTICS LTD N/A 20.12M
MDX.CA MEDX HEALTH CORP N/A 19.68M
NSCI.CA NANALYSIS SCIENTIFIC CORP N/A 17.95M
THRM.CA THERMA BRIGHT INC N/A 3.69M
VER-H.CA VERISANTE TECHNOLOGY INC N/A 878.80K
VVTM.CA VVT MED INC N/A 20.72M

Related stock screener links

About LXG.CA

Company Profile

LXG logo image Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

Company Info

LEXAGENE HOLDINGS INC

500 Cummings Ctr., Suite 4550

Beverly MASSACHUSETTS 01915 US

CEO: John F. Regan

Employees: 33

LXG Company Website

Phone: 18002151824.0

LEXAGENE HOLDINGS INC / LXG.CA FAQ

What does LXG do?

Lexagene Holdings Inc. develops biomedical devices. The company is headquartered in Beverly, Massachusetts and currently employs 33 full-time employees. The company went IPO on 2007-08-28. The firm is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The firm's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


What is the stock price of LEXAGENE HOLDINGS INC today?

The current stock price of LXG.CA is 0.105 CAD. The price decreased by -19.23% in the last trading session.


What is the dividend status of LEXAGENE HOLDINGS INC?

LXG.CA does not pay a dividend.


What is the ChartMill rating of LEXAGENE HOLDINGS INC stock?

LXG.CA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


What is the employee count for LXG stock?

LEXAGENE HOLDINGS INC (LXG.CA) currently has 33 employees.


What is LEXAGENE HOLDINGS INC worth?

LEXAGENE HOLDINGS INC (LXG.CA) has a market capitalization of 14.77M CAD. This makes LXG.CA a Nano Cap stock.